Physician profile
Suwen Kumar
NPI 1669811444
$8,184.70
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,889 · 2020: $2,464 · 2021: $3,258 · 2022: $371 · 2023: $118 · 2024: $84.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,436.56 | 2019-2024 | Rotapro |
| Abbott Laboratories | $1,389.32 | 2019-2022 | |
| Abiomed | $730.84 | 2019-2020 | |
| Cardiovascular Systems INC. | $645.68 | 2020-2022 | |
| Shockwave Medical, INC | $617.10 | 2020-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $418.95 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $404.89 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $391.87 | 2019-2023 | Farxiga |
| Terumo Medical Corporation | $353.96 | 2020-2021 | |
| Medtronic, INC. | $283.99 | 2021-2022 | |
| Amgen INC. | $205.20 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $184.73 | 2020 | |
| Philips North America LLC | $176.17 | 2020-2023 | |
| Chiesi USA, INC. | $158.88 | 2020-2023 | Cleviprex, Kengreal |
| Pfizer INC. | $151.24 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $137.95 | 2020 | |
| Biotronik INC. | $128.36 | 2021 | |
| Cardiva Medical, INC. | $91.14 | 2020-2021 | |
| Medtronic Vascular, INC. | $75.93 | 2020 | |
| Heartflow, INC. | $60.06 | 2020 | |
| Cardinal Health 200 LLC | $55.28 | 2020-2021 | |
| Penumbra, INC. | $48.50 | 2021 | |
| Getinge USA Sales, LLC | $38.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suwen Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.